Sarepta Therapeutics

Sarepta Therapeutics is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short.  We have more than 40 programs across our portfolio and currently have clinical programs in development for patients with Duchenne muscular dystrophy, Limb‐girdle muscular dystrophies and other neuromuscular and CNS‐related conditions. We are headquartered in Cambridge, Massachusetts with offices around the globe.